琥珀酸福伐曲坦
Butanedioic acid, compd. with (3R)-2,3,4,9-tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide (1:1)
产品编号 :
ACIOHC831
Cas No. :
158930-09-7
包装规格
纯度
目录价
会员专享价
库存
数量
100mg
95%
¥2100
询价
250mg
95%
¥4201
询价
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。
基础信息
CAS No.
158930-09-7
中文名称
琥珀酸福伐曲坦
英文名称
Butanedioic acid, compd. with (3R)-2,3,4,9-tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide (1:1)
别名
158930-09-7 | Frovatriptan succinate anhydrous | Frovatriptan (succinate) | UNII-36K05YF32G | 36K05YF32G | (R)-3-(Methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide succinate | DTXSID90166543 | butanedioic acid;(6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazo
标准英文名
(R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide succinate
分子式
C1 8 H2 3 N3 O5
分子量
361.40
精确分子量
361.16
SMILES
CN[C@@H]1CCC2=C(C1)C1=CC(C(N)=O)=CC=C1N2.O=C(O)CCC(=O)O
标准SMILES
CN[C@H]1CC2=C(CC1)NC1=CC=C(C=C21)C(N)=O.OC(=O)CCC(O)=O
用途
Frovatriptan succinate is used for the acute treatment of migraine attacks with or without aura in adults; it alleviates migraine symptoms by selectively activating 5-HT1B/1D receptors, thereby reversing cerebral vasodilation and inhibiting neurogenic inflammation.
InChIKey
WHTHWNUUXINXHN-SBSPUUFOSA-N